Browse Category

Earnings Reports News 15 December 2025 - 17 December 2025

Treasury Wine Estates (ASX:TWE) Stock Slides to 11-Year Low After 1H26 Earnings Outlook Cut, Buyback Cancellation and China/US Reset

Treasury Wine Estates (ASX:TWE) Stock Slides to 11-Year Low After 1H26 Earnings Outlook Cut, Buyback Cancellation and China/US Reset

Sydney, 17 December 2025 — Treasury Wine Estates Limited (ASX:TWE) shares dropped sharply on Wednesday after the Penfolds owner issued a weaker near-term earnings outlook, flagged a multi-year inventory and channel “reset” across China and the United States, and cancelled the balance of its planned on-market share buyback. TradingView+1 The sell-off pushed TWE stock down as much as 16.8% to A$4.57, its lowest level since January 2015, according to Reuters. The move marked the company’s steepest intraday decline since August 2020, underscoring how quickly investor sentiment can turn when a consumer brand’s earnings visibility fades. TradingView What Treasury Wine Estates
Tesla Stock (TSLA) After the Bell Dec. 16, 2025: Record Close Near $490 on Robotaxi Momentum — What to Know Before Wednesday’s Open

Tesla Stock (TSLA) After the Bell Dec. 16, 2025: Record Close Near $490 on Robotaxi Momentum — What to Know Before Wednesday’s Open

Tesla, Inc. (TSLA) stock finished Tuesday, December 16, 2025, at a fresh record, extending a late-2025 rally that has increasingly been driven by autonomy/robotaxi expectations rather than traditional EV demand metrics. Shares closed at about $489.88 (+3.1%), with an intraday high around $491.50, and then traded fractionally lower in after-hours as investors digested a packed set of headlines on robotaxi progress, analyst targets, and policy risk for EV adoption. Barron’s+1 Below is a detailed roundup of today’s news, forecasts, and analyst takes, plus a practical checklist of what to watch before the U.S. stock market opens Wednesday, December 17, 2025.
Nike Stock (NKE) Today: New Analyst Calls, Earnings Forecasts, and What Wall Street Expects Ahead of Nike’s Dec. 18 Report

Nike Stock (NKE) Today: New Analyst Calls, Earnings Forecasts, and What Wall Street Expects Ahead of Nike’s Dec. 18 Report

December 16, 2025 — Nike, Inc. (NYSE: NKE) is back in the spotlight as investors position for a high-stakes earnings week, with fresh analyst notes, updated forecasts, and options markets signaling a potentially sharp post-results move. Nike shares traded around $66.96 on December 16 (down about 1.2% on the session). With Nike scheduled to report fiscal Q2 2026 results on Thursday, December 18, 2025 (after the close) and host a conference call shortly afterward, today’s coverage is less about a single headline and more about the collision of expectations: can Nike show enough traction in its “Win Now” turnaround to
Dillard’s (DDS) Stock Today: Special Dividend Fallout, Q3 Results, and the Latest Analyst Forecasts (Dec. 16, 2025)

Dillard’s (DDS) Stock Today: Special Dividend Fallout, Q3 Results, and the Latest Analyst Forecasts (Dec. 16, 2025)

Dillard’s, Inc. (NYSE: DDS) is having one of those “only-in-markets” weeks: the stock recently tagged fresh highs, investors chased a $30 special dividend, and now the share price is digesting both the rally and the dividend mechanics. As of Tuesday, Dec. 16, 2025, DDS was trading around $645.61, down roughly 4.9% on the day, after opening near $678 and swinging between about $629 and $688. StockAnalysis That pullback follows a dramatic run into mid-December. Multiple market data services show DDS reaching an all-time high around $740–$742 on Dec. 11, 2025. TradingView+1 So what’s actually driving Dillard’s stock right now—and what
Accenture (ACN) Stock News Today: Morgan Stanley Upgrade, DLB Data Center Deal, and What to Watch Ahead of Earnings

Accenture (ACN) Stock News Today: Morgan Stanley Upgrade, DLB Data Center Deal, and What to Watch Ahead of Earnings

Accenture plc (NYSE: ACN) enters mid-December with two stock-moving narratives colliding at once: a fresh Wall Street vote of confidence and another targeted step deeper into the AI infrastructure buildout. On Tuesday, December 16, 2025, Morgan Stanley upgraded Accenture to Overweight and lifted its price target to $320, citing a “valuation floor” and early signs of demand stabilization and recovery. Investing.com+1 At the same time, Accenture announced it signed an agreement to acquire a 65% majority stake in DLB Associates, a U.S.-based engineering and consulting firm focused on data center development—an increasingly strategic corner of the AI economy as hyperscalers
ABIVAX Société Anonyme (ABVX) Stock News on Dec. 16, 2025: Shares Slide After Q3 Loss Widens, While Analysts Keep Buy Calls and M&A Talk Lingers

ABIVAX Société Anonyme (ABVX) Stock News on Dec. 16, 2025: Shares Slide After Q3 Loss Widens, While Analysts Keep Buy Calls and M&A Talk Lingers

December 16, 2025 — ABIVAX Société Anonyme (listed as ABVX on Euronext Paris and Nasdaq) is back in the spotlight today after publishing third-quarter 2025 financial results and reiterating a long cash runway—news that didn’t stop the stock from pulling back as investors digested widening losses and the sheer scale of the rally already priced in. In U.S. trading, Abivax’s Nasdaq-listed shares were down about 5% around mid-session, at roughly $111–$112. StockAnalysis In Paris, Abivax shares were also lower earlier in the day, with one market report citing a drop of about 5.7% during the European morning. Investing.com South Africa
Navan (NAVN) Stock Sinks on Q3 Earnings and CFO Exit: Guidance, Analyst Price Targets, and Forecasts for 2026 (Dec. 16, 2025)

Navan (NAVN) Stock Sinks on Q3 Earnings and CFO Exit: Guidance, Analyst Price Targets, and Forecasts for 2026 (Dec. 16, 2025)

Navan, Inc. (NASDAQ: NAVN) stock was one of the market’s sharpest decliners on Tuesday, December 16, 2025, sliding roughly high-teens after the company’s first post-IPO earnings report landed with a thud—and after investors digested news that the company’s CFO plans to step down early next month. Barron’s+1 The selloff is a classic public-market paradox: the operating business is still growing quickly, but the headline numbers and leadership change are triggering early “trust and timing” questions that can hit newly listed stocks especially hard. What’s driving Navan stock today By mid-session, Navan shares were down about 17%–18%, according to multiple market
16 December 2025
Pfizer Stock (PFE) Slides After 2026 Guidance: COVID Sales Drop, Patent Cliff and Analyst Forecasts in Focus

Pfizer Stock (PFE) Slides After 2026 Guidance: COVID Sales Drop, Patent Cliff and Analyst Forecasts in Focus

Pfizer Inc. (NYSE: PFE) shares fell sharply in U.S. trading on Tuesday, December 16, 2025, as investors weighed the drugmaker’s first look at full-year 2026 guidance, an updated 2025 revenue outlook, and fresh commentary on cost savings and capital allocation. By late morning ET, Pfizer stock was trading around $25, down roughly 5% on the day after swinging between the mid-$26s and just under $25. The market’s message was clear: Pfizer’s transition away from pandemic-era revenue is still a work in progress, and 2026 is shaping up as another “bridge year” where lower COVID-19 sales and patent expirations pressure results—partly
Netskope Stock (NASDAQ: NTSK) Rebounds on Dec. 16, 2025 as Wall Street Weighs Earnings, Guidance, and Valuation

Netskope Stock (NASDAQ: NTSK) Rebounds on Dec. 16, 2025 as Wall Street Weighs Earnings, Guidance, and Valuation

Netskope, Inc. (NASDAQ: NTSK) stock is back in motion on December 16, 2025, rebounding after a sharp post-earnings slide that reminded investors of a simple truth about newly public, high-growth cybersecurity names: the fundamentals can be strong and the stock can still whip around like a drone in a wind tunnel. By late morning in U.S. trading, Netskope shares were changing hands around the $20 level—up roughly 7% on the day—after closing down 8.06% on Dec. 15. StockAnalysis+1 The tug-of-war now is clear: bulls point to accelerating subscription momentum (ARR and contracted backlog), improving non-GAAP margins, and new AI-era product
Johnson & Johnson Stock (JNJ) Today: FDA Priority Voucher, Talc Verdict, Earnings Date and 2026 Growth Outlook

Johnson & Johnson Stock (JNJ) Today: FDA Priority Voucher, Talc Verdict, Earnings Date and 2026 Growth Outlook

December 16, 2025 — Johnson & Johnson stock (NYSE: JNJ) is trading lower on Tuesday after pushing to fresh highs earlier this week, as investors weigh a mix of pipeline momentum, legal headlines, and an approaching earnings update that could clarify the company’s 2026 trajectory. StockAnalysis+1 Below is what’s moving Johnson & Johnson shares right now, what Wall Street is forecasting, and the key dates JNJ stock watchers have on the calendar. JNJ stock price check: what’s happening on Dec. 16, 2025 As of late morning U.S. time on December 16, JNJ stock was trading around the $211–$212 area, down
Bank of America Stock (BAC) News Today: Near 20‑Year High, Rate‑Cut Bets Shift, and Analyst Forecasts Ahead of Q4 Earnings

Bank of America Stock (BAC) News Today: Near 20‑Year High, Rate‑Cut Bets Shift, and Analyst Forecasts Ahead of Q4 Earnings

Bank of America Corporation (NYSE: BAC) is trading near a multi‑year peak on Tuesday, December 16, 2025, with investors weighing (1) a fresh round of U.S. labor-market data that’s reshaping expectations for the Federal Reserve’s next move, (2) new regulatory and consumer-banking fee headlines, and (3) the countdown to Bank of America’s fourth‑quarter 2025 earnings report on January 14, 2026. Bank of America BAC shares were last around $54.99 (down slightly on the day), after recently printing closes in the mid‑$55s. FinancialContent BAC stock price today: Holding near a milestone level As of 16:10 UTC on Dec. 16, BAC traded
GE Aerospace Stock (GE) Today: Citi’s $386 Target, FAA LEAP Directive, Dividend Date, and What to Watch Ahead of Q4 Earnings

GE Aerospace Stock (GE) Today: Citi’s $386 Target, FAA LEAP Directive, Dividend Date, and What to Watch Ahead of Q4 Earnings

December 16, 2025 — GE Aerospace stock (NYSE: GE) traded around $299 in late morning U.S. hours Tuesday, modestly lower on the day, as investors digested a mix of fresh Wall Street coverage, a regulatory update tied to CFM’s LEAP engine family, and a steady drumbeat of defense and manufacturing headlines. StockAnalysis After a powerful 2025 run, the near-term question for many shareholders is whether GE can keep converting strong demand into deliveries and high-margin services growth—while navigating engine durability scrutiny and an increasingly high bar set by bullish analyst price targets. GE Aerospace stock price check: where GE shares
Stock Market Today: Dow and S&P 500 Turn Choppy on Delayed Jobs Data; Lennar Earnings in Focus After the Bell (Dec. 16, 2025)

Stock Market Today: Dow and S&P 500 Turn Choppy on Delayed Jobs Data; Lennar Earnings in Focus After the Bell (Dec. 16, 2025)

U.S. stocks were trading in a tight, volatile range late Tuesday morning as Wall Street digested a rare burst of catch-upeconomic data after the recent government shutdown—while investors also looked ahead to a small but potentially market-moving after-hours earnings slate led by homebuilder Lennar. Reuters+1 By late morning in New York, the Dow Jones Industrial Average, S&P 500, and Nasdaq were hovering near flat after an early dip, with sector performance telling the story: healthcare and energy were among the biggest laggards, while parts of tech held up better. Reuters+1 Why the market is wobbly today: a delayed jobs report with a mixed signal The key catalyst on Dec. 16 is the delayed
16 December 2025
Snowflake vs Alphabet: Google Cloud Backlog Hits $155B as Citi Keeps Buy on SNOW on December 16, 2025

Snowflake vs Alphabet: Google Cloud Backlog Hits $155B as Citi Keeps Buy on SNOW on December 16, 2025

As the AI boom turns data into the new battleground, investors are once again weighing a classic cloud-data dilemma: buy the focused pure-play (Snowflake) or back the diversified giant (Alphabet) with Google Cloud’s BigQuery. That debate intensified heading into December 16, 2025, after fresh analyst commentary compared Snowflake (SNOW) and Alphabet (GOOGL) side by side, and as Wall Street continued to digest Citigroup’s recent decision to keep a “Buy” on Snowflake even while trimming its price target. Nasdaq+2TipRanks+2 Meanwhile, a separate headline underscored what might be the most underappreciated driver of cloud winners in 2026: power and infrastructure. Reuters reported
B. Riley Financial (RILY) Stock: Overdue Q2 Filing, Profit Swing, Debt Cut, and Nasdaq Deadlines in Focus on Dec. 16, 2025

B. Riley Financial (RILY) Stock: Overdue Q2 Filing, Profit Swing, Debt Cut, and Nasdaq Deadlines in Focus on Dec. 16, 2025

B. Riley Financial, Inc. (NASDAQ: RILY) is back in the spotlight on December 16, 2025, after the company filed its overdue second-quarter 2025 Form 10‑Q and reported results that showed a sharp swing back to profitability—alongside a sizable reduction in total debt. The update matters for more than just the quarter’s headline numbers: it’s also directly tied to the company’s Nasdaq listing compliance timeline, which has been a central narrative for RILY investors throughout 2025. PR Newswire+2Investor Relations+2 The stock’s reaction reflected that urgency. Multiple market reports described a strong after-hours move following the filing, as traders recalibrated around two
Texas Instruments stock TXN after hours Dec. 15 2025: Goldman Sachs double downgrade, key takeaways, and what to watch before Tuesday’s open

Texas Instruments stock TXN after hours Dec. 15 2025: Goldman Sachs double downgrade, key takeaways, and what to watch before Tuesday’s open

Texas Instruments Incorporated (NASDAQ: TXN) ended regular trading on Monday, December 15, 2025 near $178 a share, and the stock’s after-hours move was modest—a sign that most of the day’s repricing happened during the session rather than in late trading. TXN closed at $177.97 and was indicated around $177.67 in after-hours trading shortly after the close, down about 0.17% in late quotes. MarketWatch So what changed today—and what should investors keep in mind before the market opens Tuesday, December 16? The short answer: Wall Street’s narrative shifted sharply after a rare, high-profile analyst move, while the broader market is heading
Procter & Gamble (PG) Stock After Hours on Dec. 15, 2025: Key News, Analyst Targets, and What to Watch Before Tuesday’s Open

Procter & Gamble (PG) Stock After Hours on Dec. 15, 2025: Key News, Analyst Targets, and What to Watch Before Tuesday’s Open

Procter & Gamble (NYSE: PG) ended Monday’s session on a strong note and then held steady in after-hours trading as investors digested two headline items from the day: an SEC filing disclosing a major executive’s planned retirement and an analyst price-target trim that still leaves room for upside. PG shares rose 1.60% to close at $145.13 in regular trading, marking a fifth straight day of gains and coming on a day when broader indexes were mixed to slightly lower. Trading volume was also elevated at about 12.9 million shares, above the stock’s recent average. MarketWatch PG stock after the bell:
Caterpillar (CAT) Stock After Hours Today (Dec. 15, 2025): What to Know Before the Market Opens Tuesday

Caterpillar (CAT) Stock After Hours Today (Dec. 15, 2025): What to Know Before the Market Opens Tuesday

Caterpillar Inc. (NYSE: CAT) shares finished Monday’s session lower and stayed slightly softer in after-hours trading—setting up a “watch the macro” open for Tuesday, December 16. After a sharp pullback late last week, the heavy equipment bellwether is now trading in a zone where incoming U.S. economic data (and the bond market’s reaction to it) could matter as much as anything Caterpillar-specific. Below is what moved Caterpillar stock today, what’s in the news after the bell, and the key releases to have on your radar before Tuesday’s opening bell. Caterpillar stock: where CAT stands after the bell on Dec. 15
UnitedHealth Group (UNH) Stock After Hours Today (Dec. 15, 2025): Key News, Analyst Forecasts, and What to Watch Before Tuesday’s Open

UnitedHealth Group (UNH) Stock After Hours Today (Dec. 15, 2025): Key News, Analyst Forecasts, and What to Watch Before Tuesday’s Open

UnitedHealth Group Incorporated (NYSE: UNH) finished Monday’s regular session modestly lower and then drifted a touch further in after-hours trading—setting up a “watch-the-macro” Tuesday morning for managed-care investors. As of 6:03 p.m. ET, UNH was down 0.28% after hours to $340.14, after closing down 0.22% at $341.10. StockAnalysis That’s not a dramatic move, but the context around health insurers is anything but quiet: industry commentary is still focused on rising medical costs and regulatory pressures, and today brought a fresh reminder of sector sensitivity when Fitch downgraded rival Humana—citing elevated utilization and weaker Medicare Advantage bonus dynamics. Reuters+1 Below is
Micron (MU) Stock After Hours Today: Shares Edge Up as Wall Street Lifts Price Targets Ahead of Dec. 17 Earnings

Micron (MU) Stock After Hours Today: Shares Edge Up as Wall Street Lifts Price Targets Ahead of Dec. 17 Earnings

Micron Technology, Inc. (NASDAQ: MU) finished Monday, December 15, 2025, with a volatile session that ultimately ended in the red—but after-hours trading turned slightly positive as investors digested a fresh wave of bullish analyst commentary heading into one of the week’s biggest semiconductor catalysts: Micron’s fiscal Q1 2026 earnings report on Wednesday, Dec. 17 (after the close). Investing.com+1 Below is what moved MU after the bell today, what analysts are forecasting as of today’s research notes, and the key risks and catalysts to track before the market opens tomorrow (Tuesday, Dec. 16, 2025). Micron stock price after the bell: MU
1 138 139 140 141 142 203

Stock Market Today

AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026
AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.
Toyota stock price rises on CEO shake-up and higher profit outlook as buyout deadline nears

Toyota stock price rises on CEO shake-up and higher profit outlook as buyout deadline nears

7 February 2026
Toyota shares rose 2% to 3,780 yen Friday after the company raised its full-year profit forecast and announced CFO Kenta Kon will replace CEO Koji Sato on April 1. Third-quarter net revenues climbed 6.8% to 38.087 trillion yen, but North America posted a 5.6 billion yen operating loss. Toyota’s U.S. ADRs closed up 2.9%. The tender offer for Toyota Industries shares closes Feb. 12.
Go toTop